Clinical Trials play an important role in many mesothelioma and asbestos-related lung cancer client treatments.  This is the recent update on Erlotinib (Tarceva) and improved survival rates in patients with advanced non-small cell lung cancer when treated with this drug after standard chemotherapy.  Read about it at http://www.curetoday.com/index.cfm/fuseaction/news.showNewsArticle/id/13/news_id/1531.